Financial pressures force health systems to lay off IT workers, marking a shift from previous trends in unfilled roles. Despite IT's potential for reducing expenses through automation, it is still often considered a first place to cut costs. Some systems outsource IT roles for tasks like transitioning to new services. While AI possesses promising potential, it hasn't yet matched the hype in yielding expected benefits.

Why health systems are laying off IT workers Beckers Hospital Review

By 2024, Amazon aims to enhance healthcare access and increase collaborations with health systems via its primary care company, One Medical. The digitally-forward mission is centered around customer ease and focuses on affordability, service engagement, choice, and quick health service discovery. To combat the prevalent healthcare fragmentation, One Medical's integration with various health systems ensures seamless and continuous patient care. Future plans include additional primary care offices and enhancing the telehealth service, Amazon Clinic.

Amazon's vision for a 'frictionless' future in healthcare Beckers Hospital Review

Mass General Brigham physician Shannon MacDonald sues New Jersey medical board over out-of-state telehealth restrictions. Telehealth increased during pandemic but is now hindered by state-by-state licensing. Argues violation of interstate commerce rules and speech restrictions.

Mass General Brigham physician sues to save telehealth Beckers Hospital Review

AlphaFold, DeepMind's AI tool for predicting protein structures, identified hundreds of thousands of new psychedelic molecules, potentially aiding antidepressant development. Despite skepticism and rivalry with experimental methods, AlphaFold's structures proved effective in drug discovery. In one case, they identified potent activators of a serotonin receptor, a target for non-hallucinogenic antidepressants. Predicted and experimental structures yielded completely different drug candidates with similar success rates. Recent advances indicate that AlphaFold may speed up projects and help discover new drugs, although they can't fully replace experiments.

AlphaFold found thousands of possible psychedelics. Will its predictions help drug discovery? Nature

Financial pressures force health systems to lay off IT workers, marking a shift from previous trends in unfilled roles. Despite IT's potential for reducing expenses through automation, it is still often considered a first place to cut costs. Some systems outsource IT roles for tasks like transitioning to new services. While AI possesses promising potential, it hasn't yet matched the hype in yielding expected benefits.

Why health systems are laying off IT workers Beckers Hospital Review

By 2024, Amazon aims to enhance healthcare access and increase collaborations with health systems via its primary care company, One Medical. The digitally-forward mission is centered around customer ease and focuses on affordability, service engagement, choice, and quick health service discovery. To combat the prevalent healthcare fragmentation, One Medical's integration with various health systems ensures seamless and continuous patient care. Future plans include additional primary care offices and enhancing the telehealth service, Amazon Clinic.

Amazon's vision for a 'frictionless' future in healthcare Beckers Hospital Review

Mass General Brigham physician Shannon MacDonald sues New Jersey medical board over out-of-state telehealth restrictions. Telehealth increased during pandemic but is now hindered by state-by-state licensing. Argues violation of interstate commerce rules and speech restrictions.

Mass General Brigham physician sues to save telehealth Beckers Hospital Review

AlphaFold, DeepMind's AI tool for predicting protein structures, identified hundreds of thousands of new psychedelic molecules, potentially aiding antidepressant development. Despite skepticism and rivalry with experimental methods, AlphaFold's structures proved effective in drug discovery. In one case, they identified potent activators of a serotonin receptor, a target for non-hallucinogenic antidepressants. Predicted and experimental structures yielded completely different drug candidates with similar success rates. Recent advances indicate that AlphaFold may speed up projects and help discover new drugs, although they can't fully replace experiments.

AlphaFold found thousands of possible psychedelics. Will its predictions help drug discovery? Nature